Repros Therapeutics Inc.® Reports Fourth Quarter and Year End 2016 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/8/2026

1. SPCX
2. SBUX
3. LEVI
4. NVDA
5. GOOGL
6. USO
7. STZ
8. CRGY
9. AAPL
10. SPY

Go back to Repros Therapeutics Inc.® Reports Fourth Quarter and Year End 2016 Financial Results

Repros Therapeutics (RPRX) Reports Q4 Loss of $0.16/Share

March 31, 2017 9:20 AM EDT

Repros Therapeutics (NASDAQ: RPRX) reported Q4 EPS of ($0.16), versus ($0.26) reported last year.

For earnings history and earnings-related data on Repros Therapeutics (RPRX) click here.

... More